Supernus Pharmaceuticals, Inc

(NASDAQ:SUPN)

Latest On Supernus Pharmaceuticals, Inc (SUPN):

Date/Time Type Description Signal Details
2023-05-10 07:37 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 18:39 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78MN/A
2023-05-09 04:36 ESTNewsSupernus Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-04 20:51 ESTNewsSupernus Pharmaceuticals pays out $402M senior convertible notesN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-lineN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q4 2022 Earnings Call TranscriptN/A
2023-02-27 20:04 ESTNewsSupernus Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-15 02:54 ESTNewsSupernus secures $150M line of credit from UBS Bank USAN/A
2023-02-10 18:44 ESTNewsSupernus: Earnings YearningsN/A
2022-11-30 06:36 ESTNewsSupernus Pharmaceuticals: Shares Could Get CheapN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87MN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 01:06 ESTNewsSupernus Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-10-10 17:31 ESTNewsSupernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatmentN/A
2022-09-10 04:18 ESTNewsSupernus Pharmaceuticals (SUPN) Investor Presentation - SlideshowN/A
2022-08-20 11:47 ESTNewsSupernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson PortfolioN/A
2022-08-07 11:02 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 17:16 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82MN/A
2022-08-04 02:17 ESTNewsSupernus Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-29 04:48 ESTNewsSupernus: A Work In ProgressN/A
2022-05-10 14:29 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 17:15 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04MN/A
2022-05-07 08:04 ESTNewsSupernus Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-05-02 09:21 ESTNewsSupernus rises on FDA label expansion of ADHD therapyN/A
2022-04-13 23:14 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-lineN/A
2022-04-04 23:36 ESTNewsSupernus Pharmaceuticals drops 2.7% on 2022 guidanceN/A
2022-03-29 12:05 ESTNewsSupernus: New BeginningsN/A
2022-03-17 23:24 ESTNewsSupernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing ruleN/A
2022-03-01 13:25 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 00:52 ESTNewsSupernus Pharmaceuticals Q4 2021 Earnings PreviewN/A
2021-12-02 05:34 ESTNewsSupernus Pharma resumed Buy at Jefferies citing Adamas acquisitionN/A
2021-11-27 01:18 ESTNewsJasper more than doubles while M&A headlines weekly healthcare performersN/A
2021-11-04 16:57 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 19:31 ESTNewsSupernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidanceN/A
2021-11-03 19:30 ESTNewsSupernus up 10% following 2021 earnings guidance boost, Q3 beatN/A
2021-11-02 23:54 ESTNewsSupernus Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-27 03:49 ESTNewsAdamas Pharmaceuticals: An Acceptable Buyout At The Perfect TimeN/A
2021-10-11 18:00 ESTNewsSupernus to acquire Adamas in a deal worth up to $850 millionN/A
2021-10-11 17:59 ESTNewsAs Supernus acquires Adamas, other Parkinson's players mixed on the dayN/A
2021-09-03 02:57 ESTNewsFDA accepts for review Supernus' Qelbree sNDA for ADHD in adultsN/A
2021-08-26 01:08 ESTNewsSupernus: Well Prepared For Upcoming ChallengesN/A
2021-08-05 13:54 ESTNewsSupernus Pharmaceuticals EPS beats by $0.23, beats on revenueN/A
2021-08-05 13:53 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-03 19:03 ESTNewsSupernus Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-30 21:28 ESTNewsSupernus Pharma appoints Opgen executive as new CFON/A
2021-07-22 02:11 ESTNewsSupernus Pharma inks supply agreement with Bachem for key ingredient in ADHD drugN/A
2021-05-05 23:52 ESTNewsSupernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidanceN/A
2021-05-05 23:51 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call TranscriptN/A
2021-05-05 03:39 ESTNewsSupernus Pharmaceuticals Q1 2021 Earnings PreviewN/A
2021-04-13 20:31 ESTNewsIRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst actionN/A

About Supernus Pharmaceuticals, Inc (SUPN):

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.

See Advanced Chart

General

  • Name Supernus Pharmaceuticals, Inc
  • Symbol SUPN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 563
  • Fiscal Year EndDecember
  • IPO Date2012-05-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.supernus.com
View More

Valuation

  • Trailing PE 11.12
  • Forward PE 20.16
  • Price/Sales (Trailing 12 Mt.) 2.76
  • Price/Book (Most Recent Quarter) 1.9
  • Enterprise Value Revenue 2.66
  • Enterprise Value EBITDA 6.58
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.02
  • Next Year EPS Estimate $1.24
  • Next Quarter EPS Estimate $0.40
  • Profit Margin 24%
  • Operating Margin 36%
  • Return on Assets 9%
  • Return on Equity 19%
  • Revenue 520.4 million
  • Earnings Per Share $2.36
  • Revenue Per Share $9.89
  • Gross Profit 467.94 million
  • Quarterly Earnings Growth 42.9%
View More

Highlights

  • Market Capitalization 1.39 billion
  • EBITDA 206.24 million
  • PE Ratio 369.82
  • PEG Ratio 1.47
  • Analyst Target Price $30.75
  • Book Value Per Share $14.09
View More

Share Statistics

  • Shares Outstanding 52.92 million
  • Shares Float 47.91 million
  • % Held by Insiders 361%
  • % Held by Institutions 101.46%
  • Shares Short 7.47 million
  • Shares Short Prior Month 7.15 million
  • Short Ratio 14.42
  • Short % of Float 21%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta 1.29
  • 52 Week High $31.99
  • 52 Week Low $15.58
  • 50 Day Moving Average 28.34
  • 200 Day Moving Average 24.03
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Supernus Pharmaceuticals, Inc (SUPN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Supernus Pharmaceuticals, Inc (SUPN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.57$0.4916.33%
2020-09-302020-11-03$155.14 million$0.74$0.27170.76%
2020-06-302020-08-17$126.73 million$0.65$0.4254.76%
2020-03-312020-05-05$N/A$0.40$0.2653.85%
2019-12-312020-02-25$100.45 million$0.62$0.595.8%
2019-09-302019-11-05$102.14 million$0.54$0.59-8.47%
2019-06-302019-08-06$104.7 million$0.61$0.601.24%
2019-03-312019-05-07$85.47 million$0.34$0.47-26.88%
2018-12-312019-02-26$115.93 million$0.48$0.2967.19%
2018-09-302018-11-06$103 million$0.52$0.4222.93%
2018-06-302018-08-07$99.54 million$0.57$0.4526.67%
2018-03-312018-05-08$90.43 million$0.49$0.3251.94%
2017-12-312018-02-27$88.44 million$0.26$0.28-7.6%
2017-09-302017-11-06$80.4 million$0.30$0.286.71%
2017-06-302017-08-02$75.83 million$0.33$0.2436.5%
2017-03-312017-05-09$57.58 million$0.19$0.25-24%
2016-12-312017-01-20$62.37 million$0.37$0.347.19%
2016-09-302016-09-30$56.81 million$1.18$0.34247.06%
2016-06-302016-08-02$51.63 million$0.18$0.1336.67%
2016-03-312016-05-04$44.19 million$0.10$0.0913.8%
2015-12-312016-03-02$43.69 million$0.14$0.06128.83%
2015-09-302015-11-03$39.36 million$0.08$0.02300%
2015-06-302015-08-04$35.68 million$0.03$0.0250%
2015-03-312015-05-05$28.74 million$0.02-$0.01300%
2014-12-312015-03-10$31.24 million$0.10-$0.12183.33%
2014-09-302014-11-11$52.49 million$0.39$0.368.33%
2014-06-302014-08-11$29.68 million$0.08-$0.15153.33%
2014-03-312014-05-12$9.08 million-$0.35-$0.4114.63%
2013-12-312014-03-12$10.34 million-$0.39-$0.5529.09%
2013-09-302013-11-12$1.26 million-$0.64-$0.674.48%
2013-06-302013-08-13$281000-$0.57-$0.6512.31%
2013-03-312013-05-13$147000-$0.60-$0.7115.49%
2012-12-312013-03-14$1.09 million-$0.51-$0.7128.17%
2012-09-302012-11-07$92000-$0.55-$0.6211.29%
2012-06-302012-08-10$91000-$0.61-$0.48-27.08%
2012-03-312012-06-07$208000-$0.42

Supernus Pharmaceuticals, Inc (SUPN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Supernus Pharmaceuticals, Inc (SUPN) Chart:

Supernus Pharmaceuticals, Inc (SUPN) News:

Below you will find a list of latest news for Supernus Pharmaceuticals, Inc (SUPN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Supernus Pharmaceuticals, Inc (SUPN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-11-15200CALL0 090.12TRUE00
2024-11-15240CALL0 055.56TRUE00
2024-11-15250CALL0 089.53TRUE00
2024-11-15260CALL0 078.63TRUE00
2024-11-15270CALL0 069.68TRUE00
2024-11-15280CALL0 066.68TRUE00
2024-11-15290CALL0 059.48TRUE00
2024-11-15300CALL0 058.72TRUE00
2024-11-15310CALL0 060.69TRUE00
2024-11-15320CALL0 00TRUE00
2024-11-15330CALL0 00FALSE00
2024-11-15340.85CALL12 1045.67FALSE0.850
2024-11-15350.77CALL0 5648.18FALSE00
2024-11-15360CALL0 00FALSE00
2024-11-15370.7CALL0 10FALSE00
2024-11-15380CALL0 00FALSE00
2024-11-15390CALL0 00FALSE00
2024-11-15400.2CALL0 10FALSE00
2024-11-15450CALL0 00FALSE00
2024-11-15200PUT0 00FALSE00
2024-11-15240PUT0 00FALSE00
2024-11-15250PUT0 00FALSE00
2024-11-15260PUT0 00FALSE00
2024-11-15270PUT0 00FALSE00
2024-11-15280PUT0 00FALSE00
2024-11-15290PUT0 00FALSE00
2024-11-15300PUT0 00FALSE00
2024-11-15310PUT0 00FALSE00
2024-11-15320PUT0 00TRUE00
2024-11-15330PUT0 044.21TRUE00
2024-11-15343.45PUT0 245.18TRUE00
2024-11-15350PUT0 042TRUE00
2024-11-15360PUT0 041.25TRUE00
2024-11-15370PUT0 039.97TRUE00
2024-11-15380PUT0 056.53TRUE00
2024-11-15390PUT0 053.15TRUE00
2024-11-15400PUT0 070.95TRUE00
2024-11-15450PUT0 083.26TRUE00
2024-12-20150CALL0 085.42TRUE00
2024-12-202012.18CALL0 1277.33TRUE00
2024-12-20220CALL0 058.82TRUE00
2024-12-20230CALL0 061.79TRUE00
2024-12-20240CALL0 057.35TRUE00
2024-12-20250CALL0 052.84TRUE00
2024-12-20260CALL0 055.3TRUE00
2024-12-20270CALL0 046.2TRUE00
2024-12-20280CALL0 050.23TRUE00
2024-12-20297.5CALL0 253.3TRUE00
2024-12-20304.2CALL0 543.41TRUE00
2024-12-20312.25CALL0 345.49TRUE00
2024-12-20322.3CALL0 244.67TRUE00
2024-12-20332.15CALL0 1647.93FALSE00
2024-12-20343.6CALL0 2846.08FALSE00
2024-12-20351.25CALL0 410FALSE00
2024-12-20361.2CALL1 1241.61FALSE1.20
2024-12-20373.21CALL0 380FALSE00
2024-12-20382.54CALL0 10FALSE00
2024-12-20401.6CALL0 3043.39FALSE00
2024-12-20450.8CALL0 10FALSE00
2024-12-20500CALL0 00FALSE00
2024-12-20150PUT0 00FALSE00
2024-12-20200.55PUT0 10FALSE00
2024-12-20221.3PUT0 10FALSE00
2024-12-20230PUT0 00FALSE00
2024-12-20242PUT0 20FALSE00
2024-12-20250.7PUT0 00FALSE00
2024-12-20260PUT0 00FALSE00
2024-12-20270PUT0 00FALSE00
2024-12-20281.2PUT0 20FALSE00
2024-12-20291.15PUT0 139.64FALSE00
2024-12-20305.05PUT0 255.91FALSE00
2024-12-20311.91PUT0 10FALSE00
2024-12-20320PUT0 052.54TRUE00
2024-12-20330PUT0 045.29TRUE00
2024-12-20343.5PUT0 550.22TRUE00
2024-12-20353.6PUT0 542.69TRUE00
2024-12-20364.1PUT0 2449.25TRUE00
2024-12-20370PUT0 052.22TRUE00
2024-12-20380PUT0 055.73TRUE00
2024-12-20400PUT0 055.46TRUE00
2024-12-20450PUT0 092.57TRUE00
2024-12-20500PUT0 0103.28TRUE00
2025-03-21150CALL0 076.07TRUE00
2025-03-21200CALL0 053.15TRUE00
2025-03-21210CALL0 058.73TRUE00
2025-03-212214.77CALL0 10054.72TRUE00
2025-03-21230CALL0 051.94TRUE00
2025-03-21240CALL0 050.08TRUE00
2025-03-21250CALL0 047.93TRUE00
2025-03-21260CALL0 047.24TRUE00
2025-03-21270CALL0 044.51TRUE00
2025-03-21280CALL0 044.48TRUE00
2025-03-21290CALL0 043.21TRUE00
2025-03-21305.3CALL0 5043.11TRUE00
2025-03-21310CALL0 043.4TRUE00
2025-03-21320CALL0 044.05TRUE00
2025-03-21333CALL0 552.59FALSE00
2025-03-21345CALL0 351.09FALSE00
2025-03-21352.6CALL0 749.53FALSE00
2025-03-21362.05CALL0 649.34FALSE00
2025-03-21372.7CALL0 10FALSE00
2025-03-21382.79CALL0 10FALSE00
2025-03-21390CALL0 00FALSE00
2025-03-21401.08CALL0 570FALSE00
2025-03-21451.2CALL0 30FALSE00
2025-03-21500CALL0 00FALSE00
2025-03-21150PUT0 00FALSE00
2025-03-21200PUT0 00FALSE00
2025-03-21210.8PUT0 20FALSE00
2025-03-21220.85PUT0 30FALSE00
2025-03-21230.7PUT0 20FALSE00
2025-03-21241.85PUT0 10FALSE00
2025-03-21251.2PUT0 10FALSE00
2025-03-21261.2PUT0 20FALSE00
2025-03-21270PUT0 00FALSE00
2025-03-21282.2PUT0 60FALSE00
2025-03-21290PUT0 045.13FALSE00
2025-03-21302.1PUT0 1048.53FALSE00
2025-03-21310PUT0 051.47FALSE00
2025-03-21320PUT0 052.05TRUE00
2025-03-21330PUT0 050.17TRUE00
2025-03-21340PUT0 052.54TRUE00
2025-03-21350PUT0 050.48TRUE00
2025-03-21360PUT0 045.09TRUE00
2025-03-21370PUT0 041.42TRUE00
2025-03-21380PUT0 046.57TRUE00
2025-03-21390PUT0 043.89TRUE00
2025-03-21400PUT0 048.1TRUE00
2025-03-21450PUT0 041.16TRUE00
2025-03-21500PUT0 052.95TRUE00

Latest SUPN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$26.54
Jun 13, 2022 7:59 PM EST78$26.52
Jun 13, 2022 7:59 PM EST12$26.53
Jun 13, 2022 7:59 PM EST100$26.52
Jun 13, 2022 7:59 PM EST113$26.54

Supernus Pharmaceuticals, Inc (SUPN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2018-09-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018029835/0000000000-18-029835-index.htm
2018-11-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018034262/0000000000-18-034262-index.htm
2018-12-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018037479/0000000000-18-037479-index.htm
2019-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019011207/0000000000-19-011207-index.htm
2019-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019012145/0000000000-19-012145-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000021545719007287/0000215457-19-007287-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000083423720008681/0000834237-20-008681-index.htm
2020-03-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000091957420002390/0000919574-20-002390-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000093247119001355/0000932471-19-001355-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000104746919000828/0001047469-19-000828-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000104746919002684/0001047469-19-002684-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918032082/0001104659-18-032082-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032502/0001104659-18-032502-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918034093/0001104659-18-034093-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918037201/0001104659-18-037201-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918039860/0001104659-18-039860-index.htm
2018-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043589/0001104659-18-043589-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043595/0001104659-18-043595-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043597/0001104659-18-043597-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918047769/0001104659-18-047769-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918050207/0001104659-18-050207-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918050920/0001104659-18-050920-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055089/0001104659-18-055089-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055660/0001104659-18-055660-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057416/0001104659-18-057416-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057845/0001104659-18-057845-index.htm
2018-10-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918060747/0001104659-18-060747-index.htm
2018-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918063964/0001104659-18-063964-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066367/0001104659-18-066367-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066998/0001104659-18-066998-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918067217/0001104659-18-067217-index.htm
2018-11-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918069011/0001104659-18-069011-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918072139/0001104659-18-072139-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918073844/0001104659-18-073844-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918074466/0001104659-18-074466-index.htm
2019-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919002327/0001104659-19-002327-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919005844/0001104659-19-005844-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919007979/0001104659-19-007979-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010743/0001104659-19-010743-index.htm
2019-02-265Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010791/0001104659-19-010791-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010794/0001104659-19-010794-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010795/0001104659-19-010795-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010796/0001104659-19-010796-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010797/0001104659-19-010797-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010798/0001104659-19-010798-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010799/0001104659-19-010799-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010800/0001104659-19-010800-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010801/0001104659-19-010801-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010802/0001104659-19-010802-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2019-03-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012549/0001104659-19-012549-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919013142/0001104659-19-013142-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919016356/0001104659-19-016356-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919018296/0001104659-19-018296-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919019961/0001104659-19-019961-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023424/0001104659-19-023424-index.htm
2019-04-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023500/0001104659-19-023500-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919027555/0001104659-19-027555-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465919028593/0001104659-19-028593-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919033130/0001104659-19-033130-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2019-07-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043062/0001104659-19-043062-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043393/0001104659-19-043393-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919076466/0001104659-19-076466-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920017388/0001104659-20-017388-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024847/0001104659-20-024847-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024848/0001104659-20-024848-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024849/0001104659-20-024849-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024850/0001104659-20-024850-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024913/0001104659-20-024913-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024915/0001104659-20-024915-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024919/0001104659-20-024919-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024920/0001104659-20-024920-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465920026188/0001104659-20-026188-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920037450/0001104659-20-037450-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050721/0001104659-20-050721-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050722/0001104659-20-050722-index.htm
2020-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920056047/0001104659-20-056047-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920077403/0001104659-20-077403-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920100179/0001104659-20-100179-index.htm
2020-10-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114365/0001104659-20-114365-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114367/0001104659-20-114367-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000010/0001356576-19-000010-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000015/0001356576-19-000015-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000019/0001356576-19-000019-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000025/0001356576-19-000025-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000030/0001356576-19-000030-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000033/0001356576-19-000033-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000041/0001356576-19-000041-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000043/0001356576-19-000043-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000045/0001356576-19-000045-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000047/0001356576-19-000047-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000049/0001356576-19-000049-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000002/0001356576-20-000002-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000004/0001356576-20-000004-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000006/0001356576-20-000006-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000010/0001356576-20-000010-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000015/0001356576-20-000015-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000018/0001356576-20-000018-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000020/0001356576-20-000020-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000023/0001356576-20-000023-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000025/0001356576-20-000025-index.htm
2020-05-12NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000029/0001356576-20-000029-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000031/0001356576-20-000031-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000033/0001356576-20-000033-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000035/0001356576-20-000035-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000037/0001356576-20-000037-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000041/0001356576-20-000041-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2020-08-11NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000048/0001356576-20-000048-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000050/0001356576-20-000050-index.htm
2020-08-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000054/0001356576-20-000054-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000056/0001356576-20-000056-index.htm
2020-08-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000059/0001356576-20-000059-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000062/0001356576-20-000062-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000064/0001356576-20-000064-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000066/0001356576-20-000066-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000068/0001356576-20-000068-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000070/0001356576-20-000070-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000072/0001356576-20-000072-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000076/0001356576-20-000076-index.htm
2018-11-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1356576/999999999718009168/9999999997-18-009168-index.htm

Supernus Pharmaceuticals, Inc (SUPN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals, Inc (SUPN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 361%
Institutional Ownership: 10146%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-29Padmanabh P. BhattSr. VP of IP, CSOSell4,393.0059.90263,153.000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-02-21Frederick M. HudsonDirectorBuy5,211.0023.99125,011.8910,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0049.88997,544.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0052.031,040,558.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOBuy7,205.009.1365,781.6514,705.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy7,500.009.1368,475.0015,000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2020-07-13Frederick M. HudsonDirectorSell920.0024.4422,484.8018,041.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy10,882.009.24100,549.6818,382.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2020-07-13Frederick M. HudsonDirectorBuy8,750.002.5622,400.0018,961.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOSell60,000.0054.393,263,352.001,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy20,000.007.90158,000.0021,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy11,250.009.24103,950.0023,750.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy8,722.007.9068,903.8028,285.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy7,457.009.2468,902.6835,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOSell3,402.0059.94203,899.214,393.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOSell15,000.0020.03300,507.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOSell5,000.0023.00115,000.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-04-25JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0045,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerSell15,000.0023.14347,034.0046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerSell15,000.0025.03375,379.5046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2019-08-23Jack A. KhattarPresident, CEOBuy7,200.0026.39189,982.08465,141.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerSell20,000.0041.53830,650.0047,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2020-07-10Jack A. KhattarPresident, CEOBuy15,625.00490,841.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOBuy5,000.0012.9864,900.0049,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2020-07-27Jack A. KhattarPresident, CEOBuy15,625.00506,466.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-02-21Carrolee BarlowDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-21GEORGES GEMAYELDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2019-06-20JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0055,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerSell35,000.0056.631,981,913.5055,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOBuy15,000.0012.98194,700.0059,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-02-21JOHN M SIEBERTDirectorBuy5,211.0023.99125,011.8960,953.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerBuy15,000.009.13136,950.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerBuy15,000.0012.98194,700.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy40,000.009.24369,600.0061,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerBuy20,000.009.13182,600.0067,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell16,250.0055.23897,542.757,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell10,882.0057.90630,067.807,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOSell368.0057.9321,316.627,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOSell7,205.0060.00432,323.067,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy20,000.009.24184,800.0075,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOBuy295.009.132,693.357,795.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy368.009.243,400.327,868.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy15,000.009.13136,950.0090,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-02-21CHARLES W III NEWHALLDirectorBuy5,211.0023.99125,011.8997,509.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm